Ethinamate is a sedative-hypnotic drug substance classified as a cyclic carbamate amide and listed as a Schedule IV controlled substance under the US Controlled Substances Act, which imposes DEA import registration requirements on all commercial shipments. As a pharmaceutical active ingredient with a narrow therapeutic application and limited modern clinical use, trade volumes are characteristically small and supplier geography concentrated. Importers must coordinate FDA admissibility review alongside DEA controlled-substance import authorization before goods can be released at the port of entry. Classification falls within the cyclic amides chapter of the Harmonized System, and admissibility is complex; consultation with a licensed customs broker and the relevant regulatory agencies is strongly advised.

AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.